Asset Planning Corporation »

Regeneron Pharmaceuticals shares owned by Asset Planning Corporation

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Asset Planning Corporation from 13F filings

Historical chart of Asset Planning Corporation investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Asset Planning Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Asset Planning Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $270k 280 962.49
2023-12-31 $246k 280 878.29
2023-09-30 $230k 280 822.96
2023-06-30 $201k 280 718.54
2023-03-31 $230k 280 821.67
2022-12-31 $202k 280 721.49

More positions owned by Asset Planning Corporation

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Natl Mun Bd Etf (DFNM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Admiral Fds Smlcp 600 Val (VIOV)
Vanguard Index Fds Value Etf (VTV)
Vanguard World Health Car Etf (VHT)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Dimensional Etf Trust Us Real Estate E (DFAR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Admiral Fds Midcp 400 Idx (IVOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf (EFA)
Realty Income (O)

View all positions for Asset Planning Corporation

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals